Menu
Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, its products advance the discovery process and improve healthcare. Bio-Rad's customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020.
1000 Alfred Nobel Dr
Hercules, California 94547-1811
Phone: 15107247000
www.bio-rad.com
Bio-Rad Laboratories, Inc. (NYSE:NYSE:BIO) Q2 2022 Earnings Conference Call July 28, 2022 06:00 PM ET Company Participants Edward Chung - Head of Investor Relations Ilan Daskal - Executive…
Bio-Rad Laboratories (NYSE: BIO ) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings Bio-Rad Laboratories beat estimated earnings by 20.71%, reporting an EPS of $3.38 versus an … Full story available on Benzinga.com
Bio-Rad Labs press release (BIO): Q2 Non-GAAP EPS of $3.38 beats by $0.67.Revenue of $691.1M (-3.5% Y/Y) beats by $26.5M.For the full-year 2022, the company now anticipates…
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2022. Second-quarter 2022 net sales were $691.1 million, a decrease of 3.5 percent compared to $715.9 million reported for the second quarter of 2021. COVID-related revenue was approximately $33 million
Bio-Rad Labs (BIO) is scheduled to announce Q2 earnings results on Thursday, July 28th, after market close.The consensus EPS Estimate is $2.71 (-23.4% Y/Y) and the consensus…
Bio-Rad Laboratories found using ticker (BIO) now have 3 analysts in total covering the stock. The consensus rating is ''Strong_Buy''. The range between the high target price and low target price is between 700 and 670 calculating the average target price we see 690. Given that the stocks previous close was at 487.95 this would indicate that there is a potential upside of 41.4%. The 50 day moving average now sits at 506.05 and the 200 day MA is 620.53. The market cap for the company is $14,685m. Company Website: https://www.bio-rad.com [stock_market_widget type="chart" template="basic" color="green" assets="BIO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $20,766m based on the market concensus. Bio-Rad Laboratories manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments.
The investment case for Bio-Rad hinges almost entirely on performance of its key equity holding, Sartorius AG. We''ve priced BIO at $515 per share and rate BIO hold.
Confused about the difference between CBD and cannabis? You’re not alone. But with some convenience stores now selling CBD — and the global CBD market projected to grow to $55 billion by 2028, according to Fortune Business Insights — the difference is something operators need to know. CBD, or cannabidiol, is one of the main…
Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD ) announces that Dr. Philip Lee Miller , of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFD''s subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors. Dr. Philip Lee Miller, MD is the Founder, Medical Director and CEO of California Age Management Institute (formerly Los Gatos Longevity Institute) established in 1996. He has been in medical practice for over 45 years. Dr. Miller has become a recognized leader in Anti-Aging integrative medicine. This started with a past association with Dr. Julian Whitaker of the Whitaker Wellness Institute in Newport Beach, California. He is currently a charter member of the American Academy for Anti-Aging Medicine. He passed the … Full story available on Benzinga.com
Multi-domain signal analysis is blurring the line between real-time oscilloscopes and real-time spectrum and signal analyzers. Fernando Gomez, Tektronix Inc. Multi-domain signal analysis is enabled by advanced oscilloscope features such as 12-bit ADC, digital down conversion (DDC), and flexible channel inputs where each can be either analog or digital. As Signal Integrity (SI) and Power […]
Titan Medical (Nasdaq:TMDI) announced today that it received an additional 180 days to regain compliance with the Nasdaq market. According to a news release, the Listing Qualifications Staff of The Nasdaq Stock Market notified the company that it received 180 extra calendar days — running through Dec. 26, 2022 — to evidence compliance with the […]
Recent industry hires and promotions include new General Managers at Providence Country Club in Charlotte, N.C., Tiburon (Calif.) Peninsula Club, and TPC River’s Bend in Maineville, Ohio; a new Director of Instruction at Baltimore (Md.) Country Club; a new Director of Culinary Operations at Cherry Hills Country Club in Cherry Hills Village, Colo.; and Executive…
